Srdan Verstovsek, Haifa Kathrin Al-Ali, John Mascarenhas, Andrew Perkins, Alessandro Maria Vannucchi, Sanjay R Mohan, Bart L Scott, Dariusz Woszczyk, Steffen Koschmieder, Regina García-Delgado, Rejt? László, Jesse S McGreivy, Wayne P Rothbaum, Jean-Jacque – 2022
BOREAS: a global, phase III study of the MDM2 inhibitor navtemadlin (KRT-232) in relapsed/refractory myelofibrosis. – Future oncology
by prodriguez | Jan 1, 2022 | Publicaciones - BE-21 | 0 comments